Does interval time between liver transplant and COVID-19 infection make the difference?

Dig Liver Dis. 2021 Feb;53(2):169-170. doi: 10.1016/j.dld.2020.08.027. Epub 2020 Aug 25.
No abstract available

Keywords: Antiviral drugs; Immunosuppression; Pneumonia.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / classification
  • Antiviral Agents / therapeutic use*
  • COVID-19* / complications
  • COVID-19* / immunology
  • COVID-19* / therapy
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / surgery*
  • Female
  • Humans
  • Immunocompromised Host / immunology*
  • Immunosuppressive Agents* / immunology
  • Immunosuppressive Agents* / therapeutic use
  • Liver Neoplasms / pathology
  • Liver Neoplasms / surgery
  • Liver Transplantation* / adverse effects
  • Liver Transplantation* / methods
  • Middle Aged
  • SARS-CoV-2 / isolation & purification
  • Time
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Immunosuppressive Agents